Barclays PLC Adicet Bio, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Barclays PLC holds 51 shares of ACET stock, worth $46. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 51 -0.0%

Holding current value

$46

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$1.07 - $1.63 $369 - $562	-345 Reduced 87.12%	51 $0
Q2 2024 Aug 14, 2024	SELL	$1.21 - $2.4 $45,136 - $89,527	-37,303 Reduced 98.95%	396 $0
Q1 2024 May 15, 2024	SELL	$1.76 - $3.45 $7,212 - $14,138	-4,098 Reduced 9.8%	37,699 $88,000
Q4 2023 Feb 15, 2024	BUY	$1.11 - $1.89 $40,327 - $68,665	36,331 Added 664.67%	41,797 $79,000
Q3 2023 Nov 07, 2023	SELL	$1.37 - $3.4 $307,821 - $763,935	-224,687 Reduced 97.63%	5,466 $7,000
Q2 2023 Aug 03, 2023	BUY	$2.13 - $7.13 $451,165 - $1.51 Million	211,815 Added 1155.06%	230,153 $559,000
Q1 2023 May 04, 2023	SELL	$5.52 - $9.23 $443,393 - $741,399	-80,325 Reduced 81.41%	18,338 $105,000
Q4 2022 Feb 13, 2023	BUY	$7.72 - $21.27 $125,496 - $345,765	16,256 Added 19.73%	98,663 $882,000
Q3 2022 Nov 03, 2022	BUY	$13.43 - $18.74 $1.09 Million - $1.52 Million	80,987 Added 5703.31%	82,407 $1.17 Million
Q2 2022 Aug 12, 2022	SELL	$10.26 - $20.81 $28,358 - $57,518	-2,764 Reduced 66.06%	1,420 $21,000
Q1 2022 May 16, 2022	BUY	$11.53 - $19.97 $48,241 - $83,554	4,184 New	4,184 $84,000

Others Institutions Holding ACET

# of Institutions

Shares Held

59.2M

Call Options Held

4.2K

Put Options Held

6.7K

Orbimed Advisors LLC San Diego, CA

11.4M
Shares

$10.4 Million
0.39% of portfolio
Tang Capital Management LLC San Diego, CA

8.22M
Shares

$7.48 Million
1.01% of portfolio
Ra Capital Management, L.P. Boston, MA

7.54M
Shares

$6.86 Million
0.15% of portfolio
Goldman Sachs Group Inc New York, NY

3.76M
Shares

$3.42 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.21M
Shares

$2.92 Million
0.0% of portfolio

View Full List

About Adicet Bio, Inc.

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36.4M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

More about ACET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account